MedPath
HSA Approval

AQUIPTA TABLET 10MG

SIN17145P

AQUIPTA TABLET 10MG

AQUIPTA TABLET 10MG

November 29, 2024

ABBVIE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantABBVIE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N02CD07

Manufacturer Information

ABBVIE PTE. LTD.

Forest Laboratories Ireland, Limited

Active Ingredients

Atogepant monohydrate eqv Atogepant

10.0mg

Atogepant

Documents

Package Inserts

Aquipta tablet PI.pdf

Approved: March 28, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AQUIPTA TABLET 10MG - HSA Approval | MedPath